34 results
DRS
EX-10.57
VIR
Vir Biotechnology Inc
23 Jun 20
Draft registration statement
12:00am
-of-pocket costs, including but not limited to raw material or equipment procurement, related to any portion of the Services begun after the Letter
8-K
EX-99.1
VIR
Vir Biotechnology Inc
25 Mar 22
Other Events
4:10pm
of the EU through a Joint Procurement Agreement with the European Commission. Additional agreements are yet to be disclosed due to confidentiality
8-K
EX-99.1
VIR
Vir Biotechnology Inc
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
, the companies also signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab.
Updated in vitro data
DRS/A
EX-10.17
h32 9fvr7wrj
7 Aug 19
Draft registration statement (amended)
12:00am
S-1
EX-10.17
xz8xt t4s8t07x420u
3 Sep 19
IPO registration
4:40pm
8-K
EX-99.2
zw3thzrzr67p3l8hc4c
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS/A
EX-10.23
2qcu p4x310icf2ijm
7 Aug 19
Draft registration statement (amended)
12:00am
S-1
EX-10.23
c31icynk76d66
3 Sep 19
IPO registration
4:40pm
10-Q
4lw62bg5
19 Nov 19
Quarterly report
4:06pm